Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature

Andrea Köhrmann, Ulrike Kämmerer, Michaela Kapp et al. · BMC Cancer · 2009 · 385 citations · Full text

Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis

Michael Herman, Galina K. Sukhova, Walter Kisiel et al. · Journal of Clinical Investigation · 2001 · 228 citations · Full text

Vascular Disease, Novel Inhibitor, Immunology +21

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma

Norihiro Sato, Antony R. Parker, Noriyoshi Fukushima et al. · Oncogene · 2004 · 174 citations · Full text

Cancer Research, Lineage Plasticity, Pancreatic Cancer +10

Inhibitory Properties of a Novel Human Kunitz-Type Protease Inhibitor Homologous to Tissue Factor Pathway Inhibitor

Lars C. Petersen, Cindy A. Sprecher, Donald C. Foster et al. · Biochemistry · 1996 · 149 citations

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential

Rita CS Figueira, Luciana Rodrigues Gomes, João Siufi Neto et al. · BMC Cancer · 2009 · 139 citations · Full text